Triptolide can induce the apoptosis of cisplatin-resistant ovarian most cancers cells and sensitize them to cisplatin 52. Several transcription components, proteins and signaling pathways are associated with the antitumor outcomes of triptolide, but its anticancer impact is especially reached by ind